A brighter future

Biomarkers that tell us which patients are at higher risk of beta cell dysfunction, drugs that could cure it and what role a dual agonist can play in preventing cardiovascular events are among the discoveries that Professor Francesco Giorgino would like to see in the near future.

To hear more from Professor Giorgino, listen to him discuss incretin-based medications with other experts in the field in our series ‘The briefing room’.